Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dumouchel JL"'
Autor:
Madhwani KR; Neuroscience Graduate Program, Brown University, Providence, RI, USA., Sayied S; Department of Neuroscience, Brown University, Providence, RI, USA., Ogata CH; Department of Biology, Brown University, Providence, RI, USA., Hogan CA; Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI, USA., Lentini JM; Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY, USA., Mallik M; Molecular Neurobiology Laboratory, Donders Institute for Brain, Cognition, and Behaviour, Radboud University, Nijmegen, NL., Dumouchel JL; Therapeutic Sciences Graduate Program, Brown University, Providence, RI, USA., Storkebaum E; Molecular Neurobiology Laboratory, Donders Institute for Brain, Cognition, and Behaviour, Radboud University, Nijmegen, NL., Fu D; Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY, USA., O'Connor-Giles KM; Department of Neuroscience, Brown University, Providence, RI, USA.; Carney Institute for Brain Sciences, Brown University, Providence, RI, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 14. Date of Electronic Publication: 2023 Nov 14.
Autor:
Hogan CA; Genetics Training Program, University of Wisconsin-Madison, Madison, WI, USA., Gratz SJ; Department of Neuroscience, Brown University, Providence, RI, USA., Dumouchel JL; Therapeutic Sciences Graduate Program, Brown University, Providence, RI, USA., Thakur RS; Department of Neuroscience, Brown University, Providence, RI, USA., Delgado A; Department of Neuroscience, Brown University, Providence, RI, USA., Lentini JM; Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY, USA., Madhwani KR; Neuroscience Graduate Training Program, Brown University, Providence, RI, USA., Fu D; Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY, USA., O'Connor-Giles KM; Department of Neuroscience, Brown University, Providence, RI, USA.; Carney Institute for Brain Science, Providence, RI, USA.
Publikováno v:
EMBO reports [EMBO Rep] 2023 Oct 09; Vol. 24 (10), pp. e56808. Date of Electronic Publication: 2023 Aug 29.
Autor:
Argikar U; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Blatter M; Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Bednarczyk D; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Chen Z; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Cho YS; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Doré M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Dumouchel JL; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Ho S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Hoegenauer K; Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Kawanami T; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Mathieu S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Meredith E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Möbitz H; Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Murphy SK; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Parthasarathy S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Soldermann CP; Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Santos J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Silver S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Skolnik S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Stojanovic A; Novartis Institutes for BioMedical Research, Basel 4002, Switzerland.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Sep 22; Vol. 65 (18), pp. 12386-12402. Date of Electronic Publication: 2022 Sep 07.
Autor:
Balhara A; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.)., Basit A; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.)., Argikar UA; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.)., Dumouchel JL; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.)., Singh S; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.)., Prasad B; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India (An.B., S.S.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (Ab.B., B.P.); Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts (U.A.A.); and Department of Molecular Pharmacology and Physiology, Brown University, Providence, Rhode Island (J.L.D.) bhagwat.prasad@wsu.edu ssingh@niper.ac.in.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2021 Jul; Vol. 49 (7), pp. 592-600. Date of Electronic Publication: 2021 May 05.
Autor:
Dumouchel JL; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Argikar UA; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Adams CM; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Prasanna G; Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ehara T; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Kim S; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Breen C; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Mogi M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2021 Jan; Vol. 51 (1), pp. 5-14. Date of Electronic Publication: 2020 Jul 21.
Autor:
Dumouchel JL; Molecular Pharmacology and Physiology Graduate Training Program, Brown University, Providence, RI, USA. jennifer_dumouchel@brown.edu., Kramlinger VM; Translational Medicine, Novartis Institutes for BioMedical Research, Inc., Cambridge, MA, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2342, pp. 781-808.
Autor:
Dumouchel JL; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Chemuturi N; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Milton MN; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Camenisch G; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Chastain J; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Walles M; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Sasseville V; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Gunduz M; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Iyer GR; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.)., Argikar UA; Pharmacokinetic Sciences (J.L.D., N.C., M.N.M., J.C., M.G., G.R.I., U.A.A.) and Preclinical Safety (V.S.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Basel, Switzerland (G.C., M.W.) upendra.argikar@novartis.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2018 Nov; Vol. 46 (11), pp. 1670-1683. Date of Electronic Publication: 2018 Aug 15.
Autor:
Gunduz M; Novartis Institutes for BioMedical Research, Inc., Pharmacokinetic Sciences, Global Biotransformation, Cambridge, Watertown, MA 02139, United States., Argikar UA; Novartis Institutes for BioMedical Research, Inc., Pharmacokinetic Sciences, Global Biotransformation, Cambridge, Watertown, MA 02139, United States., Cirello AL; Novartis Institutes for BioMedical Research, Inc., Pharmacokinetic Sciences, Global Biotransformation, Cambridge, Watertown, MA 02139, United States.; Tarveda Therapeutics, Watertown, MA 02472, United States., Dumouchel JL; Novartis Institutes for BioMedical Research, Inc., Pharmacokinetic Sciences, Global Biotransformation, Cambridge, Watertown, MA 02139, United States.
Publikováno v:
Drug metabolism letters [Drug Metab Lett] 2018; Vol. 12 (2), pp. 84-92.
Autor:
Argikar UA; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139. Electronic address: upendra.argikar@novartis.com., Dumouchel JL; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Kramlinger VM; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Cirello AL; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Gunduz M; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Dunne CE; Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523., Sohal B; Analytical Sciences and Imaging, Biotransformation Group, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2017 Sep; Vol. 106 (9), pp. 2276-2281. Date of Electronic Publication: 2017 Mar 18.
Autor:
Argikar UA; a Analytical Sciences and Imaging , Novartis Institutes for Biomedical Research, Inc , Cambridge , MA , USA., Dumouchel JL; a Analytical Sciences and Imaging , Novartis Institutes for Biomedical Research, Inc , Cambridge , MA , USA., Dunne CE; b Department of Chemistry , Colorado State University , Fort Collins , CO , USA., Bushee AJ; c GreenBanana SEO , Beverly , MA , USA.
Publikováno v:
Drug metabolism reviews [Drug Metab Rev] 2017 Aug; Vol. 49 (3), pp. 372-394. Date of Electronic Publication: 2017 May 17.